Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects

PHASE4UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 25, 2017

Primary Completion Date

May 1, 2020

Study Completion Date

May 31, 2020

Conditions
Multiple Sclerosis
Interventions
DRUG

Plegridy

Self injection into area of high adipose content. Injections include 63 and 94 microgram titration doses, and the full 125 microgram dose

DRUG

Prednisone

Take one 20 milligram prednisone tablet four to five hours prior to injections two through six of the full 125 microgram Plegridy dose.

DRUG

Tylenol Pill

Take two 325 milligram Tylenol tablets 1 hour prior to each Plegridy injection, irregardless of dosage.

Trial Locations (1)

07666

RECRUITING

Holy Name Medical Center, Teaneck

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

Holy Name Medical Center, Inc.

OTHER

NCT03424733 - Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects | Biotech Hunter | Biotech Hunter